Functional inactivation of p53 is a common event in the development of human cancer (Levine et al, 1991; Vogelstein et al, 2000), and p53 inactivation is typically caused by p53 mutations, Mdm2 overexpression and other mechanisms. This evidence concerns the gene MDM2 and cancer.